4//SEC Filing
Slilaty Steve N. 4
Accession 0001128732-19-000024
CIK 0001402328other
Filed
Sep 22, 8:00 PM ET
Accepted
Sep 23, 9:45 AM ET
Size
5.1 KB
Accession
0001128732-19-000024
Insider Transaction Report
Form 4
Slilaty Steve N.
DirectorCEO and President10% Owner
Transactions
- Award
Common Stock
2019-09-02$0.00/sh+13,000,000$13,000→ 18,869,219 total
Footnotes (1)
- [F1]Effective February 1, 2019, the Issuer effectuated a reverse stock split wherein 1 share of Common Stock was issued for each 20 shares of the issued and outstanding Common Stock of the Issuer resulting in Reporting Person owning 5,869,219 shares of Common Stock of the Issuer as of that date.
Documents
Issuer
Sunshine Biopharma, Inc
CIK 0001402328
Entity typeother
Related Parties
1- filerCIK 0001474684
Filing Metadata
- Form type
- 4
- Filed
- Sep 22, 8:00 PM ET
- Accepted
- Sep 23, 9:45 AM ET
- Size
- 5.1 KB